Bristol-Myers Squibb Company
Utility Patents
Last updated:
List of all Bristol-Myers Squibb Company patents 334 in total
| Status | Patent |
|---|---|
Grant | Utility: Activatable anti-CTLA-4 antibodies and uses thereof Filling date: 6 Sep 2025 Issue date: 14 Sep 2021 |
Grant | Utility: Combination of DR5 agonist and anti-PD-1 antagonist and methods of use Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: PET-imaging immunomodulators Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Combination therapy using an anti-fucosyl-GM1 antibody and an anti-CD137 antibody Filling date: 6 Sep 2025 Issue date: 31 Aug 2021 |
Grant | Utility: Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Treatment of Hodgkin lymphoma using an anti-PD-1 antibody Filling date: 6 Sep 2025 Issue date: 10 Aug 2021 |
Grant | Utility: Compositions for cell bioproduction and methods of using the same Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Spirocyclic compounds as farnesoid X receptor modulators Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: 5-membered and bicyclic heterocyclic amides as inhibitors of rock Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: ROR .gamma. modulators Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Treatment of renal cell carcinoma Filling date: 6 Sep 2025 Issue date: 3 Aug 2021 |
Grant | Utility: Small molecule inhibitors of Galectin-3 Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Treatment of lung cancer using a combination of an anti-PD-1 antibody and an anti-CTLA-4 antibody Filling date: 6 Sep 2025 Issue date: 27 Jul 2021 |
Grant | Utility: Immunomodulators acting as antagonists of PD-1 Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 20 Jul 2021 |
Grant | Utility: Substituted bicyclic compounds Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: CAMK2D antisense oligonucleotides and uses thereof Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Methods for the selection of binding proteins Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Oxime ether compounds Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: Triazolopyridine inhibitors of myeloperoxidase Filling date: 6 Sep 2025 Issue date: 13 Jul 2021 |
Grant | Utility: 4-azaindole compounds Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Carbazole derivatives Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Pyrimidinones as factor XIA inhibitors Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Tangential flow filtration based protein refolding methods Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Pyrimidine carboxamides as GSK-3 inhibitors Filling date: 6 Sep 2025 Issue date: 6 Jul 2021 |
Grant | Utility: Alkylphenyl compounds Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Substituted isoquionline derivatives as immunomudulators Filling date: 6 Sep 2025 Issue date: 29 Jun 2021 |
Grant | Utility: Indazole derivatives as alpha v integrin antagonists Filling date: 6 Sep 2025 Issue date: 8 Jun 2021 |
Grant | Utility: Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Sulfone pyridine alkyl amide-substituted heteroaryl compounds Filling date: 6 Sep 2025 Issue date: 1 Jun 2021 |
Grant | Utility: Cyclobutane- and azetidine-containing mono and spirocyclic compounds as .alpha.V integrin inhibitors Filling date: 6 Sep 2025 Issue date: 25 May 2021 |
Grant | Utility: Quinazolines as potassium ion channel inhibitors Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Triazole n-linked carbamoyl cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonists Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Antibodies to TIGIT Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Piperidinone formyl peptide 2 receptor agonists Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Triazolopyridine inhibitors of myeloperoxidase and/or EPX Filling date: 6 Sep 2025 Issue date: 18 May 2021 |
Grant | Utility: Libraries of modified fibronectin type III tenth domain-containing polypeptides Filling date: 6 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Imaging methods using 18F-radiolabeled biologics Filling date: 6 Sep 2025 Issue date: 4 May 2021 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 27 Apr 2021 |
Grant | Utility: Biaryl kinase inhibitors Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Toll-like receptor 7 (TLR7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Thioether triazolopyridine and triazolopyrimidine inhibitors of myeloperoxidase Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: CXCL11 and SMICA as predictive biomarkers for efficacy of anti-CTLA4 immunotherapy Filling date: 6 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the same Filling date: 6 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Aryl dihydropyridinones and piperidinone MGAT2 inhibitors Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Grant | Utility: 3-substituted propionic acids as .alpha.V integrin inhibitors Filling date: 6 Sep 2025 Issue date: 6 Apr 2021 |
Showing 100 to 150 of 334 patents.